tetano
Editor, Senior Moderator
NEJM Evid
. 2024 Jul;3(7):EVIDoa2300361.
doi: 10.1056/EVIDoa2300361. Epub 2024 Jun 25. Influenza Infection and Acute Myocardial Infarction
Annemarijn R de Boer[SUP] 1 [/SUP], Annelies Riezebos-Brilman[SUP] 2 [/SUP], Denise van Hout[SUP] 1 [/SUP], Maaike S M van Mourik[SUP] 3 [/SUP], Lidewij W Rümke[SUP] 3 [/SUP], Marieke L A de Hoog[SUP] 1 [/SUP], Ilonca Vaartjes[SUP] 1 [/SUP], Patricia C J L Bruijning-Verhagen[SUP] 1 [/SUP]
Affiliations
Background: Acute respiratory infections can trigger acute myocardial infarction. We aimed to quantify the association between laboratory-confirmed influenza infection and acute myocardial infarction, particularly in patients with and without known coronary artery disease.
Methods: This observational, registry-based, self-controlled case series study evaluated the association between laboratory-confirmed influenza infection and occurrence of acute myocardial infarction. Laboratory records on respiratory virus polymerase chain reaction (PCR) testing from 16 laboratories across the Netherlands were linked to national mortality, hospitalization, medication, and administrative registries. Influenza infection was defined as a positive PCR test result. Acute myocardial infarction was defined as a registered diagnostic code for either acute myocardial infarction hospitalization or death. Using a self-controlled case series method, we then compared the incidence of acute myocardial infarction during the risk period (days 1 to 7 after influenza infection) versus the control period (1 year before and 51 weeks after the risk period).
Results: Between 2008 and 2019, we identified 158,777 PCR tests for influenza in the study population; 26,221 were positive for influenza, constituting 23,405 unique influenza illness episodes. A total of 406 episodes were identified with acute myocardial infarction occurring within 1 year before and 1 year after confirmed influenza infection and were included in analysis. Twenty-five cases of acute myocardial infarction occurred during the risk period versus 394 during the control period. The adjusted relative incidence of acute myocardial infarction during the risk period compared with the control period was 6.16 (95% confidence interval [CI], 4.11 to 9.24). The relative incidence of acute myocardial infarction in individuals without prior hospitalization for coronary artery disease was 16.60 (95% CI, 10.45 to 26.37) compared with 1.43 (95% CI, 0.53 to 3.84) for those with prior admission for coronary artery disease.
Conclusions: Influenza infection was associated with an increased risk of acute myocardial infarction, especially in individuals without a prior hospitalization for coronary artery disease. (Funded by the Dutch Research Council [NWO].).
. 2024 Jul;3(7):EVIDoa2300361.
doi: 10.1056/EVIDoa2300361. Epub 2024 Jun 25. Influenza Infection and Acute Myocardial Infarction
Annemarijn R de Boer[SUP] 1 [/SUP], Annelies Riezebos-Brilman[SUP] 2 [/SUP], Denise van Hout[SUP] 1 [/SUP], Maaike S M van Mourik[SUP] 3 [/SUP], Lidewij W Rümke[SUP] 3 [/SUP], Marieke L A de Hoog[SUP] 1 [/SUP], Ilonca Vaartjes[SUP] 1 [/SUP], Patricia C J L Bruijning-Verhagen[SUP] 1 [/SUP]
Affiliations
- PMID: 38916418
- DOI: 10.1056/EVIDoa2300361
Background: Acute respiratory infections can trigger acute myocardial infarction. We aimed to quantify the association between laboratory-confirmed influenza infection and acute myocardial infarction, particularly in patients with and without known coronary artery disease.
Methods: This observational, registry-based, self-controlled case series study evaluated the association between laboratory-confirmed influenza infection and occurrence of acute myocardial infarction. Laboratory records on respiratory virus polymerase chain reaction (PCR) testing from 16 laboratories across the Netherlands were linked to national mortality, hospitalization, medication, and administrative registries. Influenza infection was defined as a positive PCR test result. Acute myocardial infarction was defined as a registered diagnostic code for either acute myocardial infarction hospitalization or death. Using a self-controlled case series method, we then compared the incidence of acute myocardial infarction during the risk period (days 1 to 7 after influenza infection) versus the control period (1 year before and 51 weeks after the risk period).
Results: Between 2008 and 2019, we identified 158,777 PCR tests for influenza in the study population; 26,221 were positive for influenza, constituting 23,405 unique influenza illness episodes. A total of 406 episodes were identified with acute myocardial infarction occurring within 1 year before and 1 year after confirmed influenza infection and were included in analysis. Twenty-five cases of acute myocardial infarction occurred during the risk period versus 394 during the control period. The adjusted relative incidence of acute myocardial infarction during the risk period compared with the control period was 6.16 (95% confidence interval [CI], 4.11 to 9.24). The relative incidence of acute myocardial infarction in individuals without prior hospitalization for coronary artery disease was 16.60 (95% CI, 10.45 to 26.37) compared with 1.43 (95% CI, 0.53 to 3.84) for those with prior admission for coronary artery disease.
Conclusions: Influenza infection was associated with an increased risk of acute myocardial infarction, especially in individuals without a prior hospitalization for coronary artery disease. (Funded by the Dutch Research Council [NWO].).